NCT02029482View on ClinicalTrials.gov

Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Safety and Tolerability
Interventions
DRUG

ACT-128800

DRUG

Placebo

Trial Locations (1)

SE1 1YR

Quintiles Drug Research Unit at Guy's Hospital, London

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT02029482 - Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects | Biotech Hunter | Biotech Hunter